November 19, 2024
Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India.
November 19, 2024
Boehringer Ingelheim India and RED.Health ambulance services sign MOU to strengthen emergency stroke care in pre-hospital setup in India.
August 23, 2024
Boehringer Ingelheim India and Vvaan Lifesciences Pvt Ltd announce strategic distribution partnership to expand pet portfolio reach.
July 12, 2024
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
May 15, 2024
CDSCO approves SPEVIGO® (spesolimab) - the first treatment option for generalized pustular psoriasis flares in adults
April 18, 2024
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
February 14, 2024
Jardiance® (empagliflozin) now approved in India for the treatment of adults with chronic kidney disease
February 01, 2024
Boehringer Ingelheim India earns ‘‘Top Employer 2024’’ accolade for second consecutive year
September 20, 2023
Boehringer Ingelheim India joins forces with Pet Practitioners Association of Mumbai (PPAM) and Brihanmumbai Municipal Corporation (BMC) to ‘Stop Rabies’ in Mumbai
August 10, 2023
Boehringer Ingelheim expands animal health portfolio in India with the launch of NexGard® (afoxolaner) Small and Medium
June 26, 2023
Boehringer Ingelheim announces appointment of Gagandeep Singh as Managing Director and Head of Human Pharma for India
Media Contacts
Director, Communications, Boehringer Ingelheim India
Senior Manager, Communications, Boehringer Ingelheim India